SEC Form 4 · accession 0000899243-18-007087
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
Mar 1, 2018
Accepted (ET)
Mar 12, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.08 | Mar 1, 2018 | A | 90,000 | A | — | Mar 1, 2028 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1The stock option vests in 48 equal monthly installments commencing March 1, 2018.